SK Biopharm strikes $800m deal for epilepsy drug from Biohaven

--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-08-26 16:05 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Military & Defence, Drugs, World News
--------------------------------------------------------------------
Snippet:
SK Biopharmaceuticals is staking nearly $800 million on rights to an epilepsy treatment from US biotech firm Biohaven, the company said Wednesday.
--------------------------------------------------------------------
>>> Read full article at The Korea Herald <<<
<-- Back to Home
< >
[Close]